1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
680F735F17749F08485257A720074C649
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/medical-affairs-changing-landscape-otc-success?opendocument
18
19opendocument
2054.90.204.233
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services »

Research Webcast Series: Four Benchmarks of Success in OTC Medical Affairs' Changing Landscape

ID: WEB-32


Pages: 1


Published: Pre-2013


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Overview

Based on recent research by Best Practices, LLC, this webcast will highlight critical benchmarks and exclusive insights detailing how OTC
Medical Affairs organizations are responding quickly and adapting successfully to the changing OTC landscape.



Expect to learn:

  • Understanding the changing landscape of OTC and the impact of Medical Affairs
  • Winning thought leader support in established OTC markets
  • Managing relationships with key stakeholders throughout a product rollout
  • Interacting with pharmacists through scientific messaging and useful education collateral
  • Communicating to the customer at point-of-care to create demand and drive sales

Date and time:

Thursday, September 13 at 11:00 AM -11:45 AM EDT
Tuesday, September 18 at 11:00 AM -11:45 AM EDT


Invited attendees: Executives and managers who lead or oversee Medical Affairs, Managed Markets, Pharmacy Relations at pharmaceutical and biotechnology companies are invited to attend. Leaders of KOL management and Advocacy leaders may also benefit from attending this research webcast.


Speakers: Melvin Hines, Jr. and Cameron Tew

Melvin Hines, Jr.
Research and Legal Consultant

Melvin Hines is a Research Consultant and heads the legal team at Best Practices, LLC. Melvin has worked on various projects for several major players in the pharmaceutical industry, including GlaxoSmithKline, Merck, Novartis, Novo Nordisk. Melvin also provides strategic legal insight for a variety of internal operations. Prior to joining Best Practices, Melvin worked as a consultant for many non-profit organizations around the world. He also serves as an adjunct professor at North Carolina Central University's School of Law in Durham, North Carolina. Melvin holds a Juris Doctor and an MBA from Duke University, and a B.B.A. in Economics from the University of Georgia.


Cameron Tew
Executive Director of Research

Cameron Tew joined Best Practices, LLC, in early 2004, bringing a wealth of experience in research, analysis, field interviews and management/project leadership from 14 years in the media industry. Cameron works directly with clients on existing initiatives and also contributes to the development of new services to help biopharmaceutical and medical device companies improve their commercial operations.

Cameron has delivered industry presentations on a breadth of topics including new product planning, product launch, competitive intelligence, Medical Affairs, Medical Science Liaisons, sales communication and talent management. He has been published and quoted in various industry and technology publications including Med Ad News, Pharma Voice, Pharma Focus, First Word Reports, Product Management Today, Pharmaceutical Technology and Innovations in Pharma Technology.


System Requirements:

PC-based attendees
Required: Windows® 7, Vista, XP or 2003 Server
Macintosh®-based attendees
Required: Mac OS® X 10.6 or newer
Mobile attendees
Required: iPhone®, iPad®, Android™ phone or Android tablet

Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research


Companies Profiled:
Pharma; Biotech; Medical Device Companies